DNLI
Denali Therapeutics Inc.Company with tickers: DNLI
CIK
1714899
CUSIP
24823R105
Shares Outstanding
158,709,737
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 0 |
| 2026-04-10 | Chin Peter Scott | Chief Medical Officer | Other | 170,612 |
| 2026-01-06 | Watts Ryan J. | Director, President and CEO | Sell | 35,198 |
| 2026-01-06 | Watts Ryan J. | Director, President and CEO | Other | 2,152,604 |
| 2026-01-06 | Schuth Alexander O. | COFO and Secretary | Sell | 17,218 |
| 2026-01-06 | Schuth Alexander O. | COFO and Secretary | Other | 523,749 |
| 2026-01-03 | Watts Ryan J. | Director, President and CEO | Award | 236,880 |
| 2026-01-03 | Watts Ryan J. | Director, President and CEO | Award | 78,960 |
| 2026-01-03 | Watts Ryan J. | Director, President and CEO | Other | 2,152,604 |
| 2026-01-03 | Schuth Alexander O. | COFO and Secretary | Other | 523,749 |
| 2026-01-03 | Schuth Alexander O. | COFO and Secretary | Award | 57,700 |
| 2026-01-03 | Schuth Alexander O. | COFO and Secretary | Award | 173,100 |
| 2025-12-11 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Buy | 2,095,191 |
| 2025-12-11 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Buy | 190,523 |
| 2025-11-04 | Van Hauwermeiren Timothy | Director | Other | 0 |
| 2025-11-04 | Van Hauwermeiren Timothy | Director | Award | 10,632 |
| 2025-11-04 | Van Hauwermeiren Timothy | Director | Award | 31,897 |
| 2025-09-03 | Watts Ryan J. | Director, President and CEO | Other | 253,071 |
| 2025-09-03 | Watts Ryan J. | Director, President and CEO | Gift | 50,000 |
| 2025-08-13 | Ho Carole | EVP & Pres, Lilly Neuroscience | Sell | 806 |
| 2025-08-12 | Ho Carole | EVP & Pres, Lilly Neuroscience | Other | 183,219 |
| 2025-08-12 | Ho Carole | EVP & Pres, Lilly Neuroscience | Other | 25,000 |
| 2025-08-12 | Ho Carole | EVP & Pres, Lilly Neuroscience | Sell | 2,937 |
| 2025-08-12 | Schuth Alexander O. | COFO and Secretary | Other | 523,749 |
| 2025-08-12 | Schuth Alexander O. | COFO and Secretary | Sell | 2,937 |
| 2025-08-05 | Ho Carole | EVP & Pres, Lilly Neuroscience | Convert | 44,655 |
| 2025-08-05 | Ho Carole | EVP & Pres, Lilly Neuroscience | Other | 183,219 |
| 2025-08-05 | Ho Carole | EVP & Pres, Lilly Neuroscience | Convert | 44,655 |
| 2025-08-05 | Ho Carole | EVP & Pres, Lilly Neuroscience | Other | 25,000 |
| 2025-07-09 | Watts Ryan J. | Director, President and CEO | Sell | 495,282 |
| 2025-07-09 | Watts Ryan J. | Director, President and CEO | Convert | 40,000 |
| 2025-07-09 | Watts Ryan J. | Director, President and CEO | Convert | 455,282 |
| 2025-07-09 | Watts Ryan J. | Director, President and CEO | Other | 2,202,604 |
| 2025-07-09 | Watts Ryan J. | Director, President and CEO | Convert | 455,282 |
| 2025-07-09 | Watts Ryan J. | Director, President and CEO | Convert | 40,000 |
| 2025-06-03 | BAKER JULIAN | Director | Other | 0 |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Other | 3,405,393 |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Other | 0 |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Other | 326,302 |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Other | 0 |
| 2025-06-03 | Cook Jennifer E. | Director | Award | 18,111 |
| 2025-06-03 | Cook Jennifer E. | Director | Award | 6,037 |
| 2025-06-03 | FLATLEY JAY T | Director | Award | 6,037 |
| 2025-06-03 | FLATLEY JAY T | Director | Award | 18,111 |
| 2025-06-03 | FLATLEY JAY T | Director | Other | 336,313 |
| 2025-06-03 | Klein Peter S | Director | Award | 18,111 |
| 2025-06-03 | Klein Peter S | Director | Award | 6,037 |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 31,695 |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 31,695 |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 10,565 |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Award | 10,565 |
| 2025-06-03 | Krognes Steve E. | Director | Other | 781,797 |
| 2025-06-03 | Krognes Steve E. | Director | Award | 6,037 |
| 2025-06-03 | Schenkein David P | Director | Other | 31,232 |
| 2025-06-03 | Schenkein David P | Director | Award | 6,037 |
| 2025-06-03 | Schenkein David P | Director | Other | 26,232 |
| 2025-06-03 | Schenkein David P | Director | Award | 18,111 |
| 2025-06-03 | Thornberry Nancy | Director | Award | 6,037 |
| 2025-06-03 | Thornberry Nancy | Director | Award | 18,111 |
| 2025-06-03 | Tessier-Lavigne Marc | Director | Other | 78,848 |
| 2025-06-03 | Tessier-Lavigne Marc | Director | Other | 78,848 |
| 2025-06-03 | Tessier-Lavigne Marc | Director | Award | 6,037 |
| 2025-06-03 | Tessier-Lavigne Marc | Director | Other | 79,173 |
| 2025-06-03 | Tessier-Lavigne Marc | Director | Award | 18,111 |
| 2025-06-03 | Krognes Steve E. | Director | Award | 18,111 |
| 2025-01-07 | Ho Carole | EVP & Pres, Lilly Neuroscience | Sell | 2,907 |
| 2025-01-07 | Schuth Alexander O. | COFO and Secretary | Sell | 2,907 |
| 2025-01-07 | Watts Ryan J. | Director, President and CEO | Sell | 7,650 |
| 2025-01-07 | Krognes Steve E. | Director | Sell | 3,339 |
| 2025-01-07 | Krognes Steve E. | Director | Other | 781,797 |
| 2025-01-06 | Ho Carole | EVP & Pres, Lilly Neuroscience | Sell | 12,255 |
| 2025-01-06 | Ho Carole | EVP & Pres, Lilly Neuroscience | Other | 183,219 |
| 2025-01-06 | Ho Carole | EVP & Pres, Lilly Neuroscience | Other | 25,000 |
| 2025-01-06 | Schuth Alexander O. | COFO and Secretary | Other | 523,749 |
| 2025-01-06 | Schuth Alexander O. | COFO and Secretary | Sell | 12,255 |
| 2025-01-06 | Watts Ryan J. | Director, President and CEO | Sell | 29,266 |
| 2025-01-06 | Watts Ryan J. | Director, President and CEO | Other | 2,202,604 |
| 2025-01-03 | Watts Ryan J. | Director, President and CEO | Award | 54,180 |
| 2025-01-03 | Watts Ryan J. | Director, President and CEO | Award | 162,540 |
| 2025-01-03 | Watts Ryan J. | Director, President and CEO | Other | 2,202,604 |
| 2025-01-03 | Schuth Alexander O. | COFO and Secretary | Other | 523,749 |
| 2025-01-03 | Schuth Alexander O. | COFO and Secretary | Award | 162,540 |
| 2025-01-03 | Schuth Alexander O. | COFO and Secretary | Award | 54,180 |
| 2025-01-03 | Ho Carole | EVP & Pres, Lilly Neuroscience | Other | 183,219 |
| 2025-01-03 | Ho Carole | EVP & Pres, Lilly Neuroscience | Award | 54,180 |
| 2025-01-03 | Ho Carole | EVP & Pres, Lilly Neuroscience | Other | 25,000 |
| 2025-01-03 | Ho Carole | EVP & Pres, Lilly Neuroscience | Award | 162,540 |
| 2025-01-02 | SATO VICKI L | Director | Sell | 3,080 |
| 2024-12-31 | Krognes Steve E. | Director | Sell | 30,000 |
| 2024-12-31 | Krognes Steve E. | Director | Other | 781,797 |
| 2024-12-27 | Schuth Alexander O. | COFO and Secretary | Convert | 6,708 |
| 2024-12-27 | Schuth Alexander O. | COFO and Secretary | Other | 523,749 |